RAPT Therapeutics, Inc. (RAPT) Profit After Tax (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Profit After Tax for 5 consecutive years, with -$53.3 million as the latest value for Q4 2024.
- Quarterly Profit After Tax fell 72.57% to -$53.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$129.9 million through Dec 2024, down 11.22% year-over-year, with the annual reading at -$129.9 million for FY2024, 11.22% down from the prior year.
- Profit After Tax hit -$53.3 million in Q4 2024 for RAPT Therapeutics, down from -$18.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$12.4 million in Q2 2020 to a low of -$53.3 million in Q4 2024.
- Historically, Profit After Tax has averaged -$22.6 million across 5 years, with a median of -$19.8 million in 2022.
- Biggest YoY gain for Profit After Tax was 41.25% in 2024; the steepest drop was 72.57% in 2024.
- Year by year, Profit After Tax stood at -$12.7 million in 2020, then plummeted by 40.79% to -$17.9 million in 2021, then fell by 28.01% to -$23.0 million in 2022, then plummeted by 34.53% to -$30.9 million in 2023, then tumbled by 72.57% to -$53.3 million in 2024.
- Business Quant data shows Profit After Tax for RAPT at -$53.3 million in Q4 2024, -$18.4 million in Q3 2024, and -$27.7 million in Q2 2024.